169 related articles for article (PubMed ID: 27140184)
1. New Hopes in Cancer Battle - A Review of New Molecules and Treatment Strategies.
Turek M; Krzyczmonik M; Balczewski P
Med Chem; 2016; 12(8):700-719. PubMed ID: 27140184
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
4. Natural products to prevent drug resistance in cancer chemotherapy: a review.
Yuan R; Hou Y; Sun W; Yu J; Liu X; Niu Y; Lu JJ; Chen X
Ann N Y Acad Sci; 2017 Aug; 1401(1):19-27. PubMed ID: 28891091
[TBL] [Abstract][Full Text] [Related]
5. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
Shi Q; Zhang L; Liu M; Zhang X; Zhang X; Xu X; Chen S; Li X; Zhang J
Biomaterials; 2015 Oct; 67():169-82. PubMed ID: 26218743
[TBL] [Abstract][Full Text] [Related]
6. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
Sun H; Yarovoy I; Capeling M; Cheng C
Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
[TBL] [Abstract][Full Text] [Related]
7. Polyether ionophores-promising bioactive molecules for cancer therapy.
Huczyński A
Bioorg Med Chem Lett; 2012 Dec; 22(23):7002-10. PubMed ID: 23063400
[TBL] [Abstract][Full Text] [Related]
8. Chemical approaches to targeting drug resistance in cancer stem cells.
Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
[TBL] [Abstract][Full Text] [Related]
9. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in cancer and chemotherapy.
Yousefi S; Simon HU
Results Probl Cell Differ; 2009; 49():183-90. PubMed ID: 19142622
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
12. [Advance in studies on molecular mechanisms of cisplatin resistance and intervention with traditional Chinese medicines].
Liu L; Bian K
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3216-20. PubMed ID: 25522600
[TBL] [Abstract][Full Text] [Related]
13. Cancer therapy: new targets for chemotherapy.
Novotny L; Szekeres T
Hematology; 2003 Jun; 8(3):129-37. PubMed ID: 12745645
[TBL] [Abstract][Full Text] [Related]
14. Cellular targets for anticancer strategies.
La Porta CA
Curr Drug Targets; 2004 May; 5(4):347-55. PubMed ID: 15134217
[TBL] [Abstract][Full Text] [Related]
15. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells.
Liu J; He Y; Zhang D; Cai Y; Zhang C; Zhang P; Zhu H; Xu N; Liang S
Mol Med Rep; 2017 Sep; 16(3):2595-2603. PubMed ID: 28677760
[TBL] [Abstract][Full Text] [Related]
16. Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity.
Bisi A; Cappadone C; Rampa A; Farruggia G; Sargenti A; Belluti F; Di Martino RMC; Malucelli E; Meluzzi A; Iotti S; Gobbi S
Eur J Med Chem; 2017 Feb; 127():577-585. PubMed ID: 28109950
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.
Spänkuch B; Strebhardt K
Curr Pharm Des; 2008; 14(11):1098-112. PubMed ID: 18473857
[TBL] [Abstract][Full Text] [Related]
18. Introduction to resistance to anticancer agents.
Kruh GD
Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
[No Abstract] [Full Text] [Related]
19. Statins anticancer targeted delivery systems: re-purposing an old molecule.
Safwat S; Ishak RA; Hathout RM; Mortada ND
J Pharm Pharmacol; 2017 Jun; 69(6):613-624. PubMed ID: 28271498
[TBL] [Abstract][Full Text] [Related]
20. [Progress in the study of targeted drug delivery systems for cancer stem cells].
Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
